Table 2 Prevalence and factors associated with absence of HCV RNA among newly identified HCV antibody positive patients, UCLA Health system, November 2015–2017
HCV RNA negative | P value | Unadjusted OR (95% Cl) | Adjusted OR (95% CI) | ||
|---|---|---|---|---|---|
n | % | ||||
Total | 185 | 58.0 | – | – | – |
Age group (years) | 0.17 | ||||
18–52 | 58 | 58.6 | Ref | Ref | |
52–72 (“Baby Boomers”) | 118 | 59.6 | 1.04 (0.64–1.70) | 1.35 (0.75–2.39) | |
≥ 73 | 9 | 39.1 | 0.45 (0.18–1.15) | 0.45 (0.16–1.30) | |
Sex | 0.07 | ||||
Male | 95 | 53.1 | Ref | Ref | |
Female | 88 | 63.3 | 1.53 (0.97–2.40) | 1.53 (0.91–2.56) | |
Race/Ethnicity | 0.02 | ||||
Asian | 3 | 60.0 | 1.08 (0.18–6.59) | 1.00 (0.14–5.44) | |
Black or African American | 14 | 36.8 | 0.42 (0.21–0.86) | 0.43 (0.21–0.92) | |
Hispanic or Latino | 10 | 40.0 | 0.48 (0.20–1.12) | 0.63 (0.26–1.57) | |
Othera | 27 | 82.0 | 3.87 (1.43–10.51) | 4.38 (1.54–12.44) | |
White or Caucasian | 106 | 58.2 | Ref | Ref | |
Clinical Characteristics | |||||
HIV Positive | 0.33 | ||||
Yes | 4 | 40.0 | 0.48 (0.13–1.73) | – | |
No | 180 | 58.3 | Ref | ||
Chronic Kidney Diseaseb | 0.06 | ||||
Yes | 9 | 39.1 | 0.45 (0.19–1.06) | 0.37 (0.14–1.03) | |
No | 173 | 59.0 | Ref | Ref | |
Diabetes Mellitus | 0.76 | ||||
Yes | 25 | 55.6 | 0.91 (0.48–1.71) | – | |
No | 157 | 57.9 | Ref | ||